Product
SHR2554/CHOP
1 clinical trial
1 indication
Indication
Peripheral T-cell LymphomaClinical trial
A Phase Ib/II, Open-label, Multi-center Study of SHR2554 With CHOP/CHOEP in Treatment-naïve Patients With Peripheral T-cell LymphomaStatus: Not yet recruiting, Estimated PCD: 2025-12-31